Events Partner Content Cell and Gene Therapy Manufacturing Forum Last year we told you that the cell and gene industry would be worth $9 - $14 billion by 2026. We were wrong.
Views & Analysis Continuous bioprocessing – the key to industrialising gene t... A new partnership, with funding from Innovate UK, aims to investigate the possibility of using continuous manufacturing processes in gene therapy.
News UK gene and cell therapy manufacturing hub clears regulatory... The UK's regulator has granted new licences to a hub of biotech companies to allow them to continue manufacturing of groundbreaking gene and cell therapies at an innovative purpose-built ce
News Sanofi invests in new Canadian vaccine manufacturing plant Sanofi is investing 350 million euros in a new vaccine manufacturing facility at its Canadian headquarters in Toronto.
News Pharma urges Scotland to invest in R&D, manufacturing Pharma industry driving growth where job prospects are weaker
Partner Content Partner Content Hot Sessions You Cannot Afford to Miss at SMi’s Lyophilizati... 3 Weeks to go for #LYOUSA
News Takeda gets first OK for orexin narcolepsy drug, in China China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder narcolepsy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.